콜마바이오텍

215380KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

2,190KRWMarket close of 10/20 (Tue)

Down -0.45%-10KRWMarket close of 10/20 (Tue)

Open
2,255
High
2,255
Low
2,140
Day range
Day range low 2,140 high 2,255, open 2,255, close 2,190, previous close 2,200
Volume
3×10K shares
72.03 million KRW 0.32× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 1,714 to 3,605 won, 25% up from the low

25% of the way up from the lowest close in 1 year (252 sessions) · -39.3% from the high

Usual range

Nothing unusual in the 3 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedThe last four quarters are incomplete, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-0.45%usual range
  • Trading value0.3×usual range
  • Data date10/20 (Tue)Market close
See the full check report

Filings in the last 2 years · 1

Annual reportHalf-year reportQuarterly reportMaterial eventAmended

Material events are checked for the top 400 stocks only — this stock shows periodic reports only.

  1. 2026-08-14Half-year report (2026.06)

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -9.6%Down -3.35%51.1B KRW
올릭스Close over the last 20 sessions -12.2%Down -4.03%19.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
리가켐바이오Close over the last 20 sessions -15.4%Down -1.41%12.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 26 days
  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.